Dulaglutide slows kidney disease in type 2 diabetes

Lancet. 2020 Feb 22;395(10224):559. doi: 10.1016/S0140-6736(19)32550-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Glucagon-Like Peptides / analogs & derivatives
  • Humans
  • Immunoglobulin Fc Fragments
  • Kidney Diseases*
  • Recombinant Fusion Proteins

Substances

  • Immunoglobulin Fc Fragments
  • Recombinant Fusion Proteins
  • Glucagon-Like Peptides
  • dulaglutide